Advertisement

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Pharmaceuticals

Single agent targets three parasitic infections

Discovery could lead to improved drugs for Chagas disease, leishmaniasis, and sleeping sickness

by Stu Borman
August 8, 2016

Article:

This article has been sent to the following recipient: